Exercise of Options, Director Dealings and TVR

Accrol group

23/07/2021 14:31

RNS Number : 3368G

Accrol Group Holdings PLC

23 July 2021

 

 

23 July 2021

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

Accrol Group Holdings plc

("Accrol" or the "Company")

 

Exercise of Options, Director Dealings and Total Voting Rights

 

Accrol (AIM:ACRL), the UK's leading independent tissue convertor, announces the Company has today issued 7,523,465 new ordinary shares of £0.001 each ("Ordinary Shares") in the Company (the "Option Shares") pursuant to the exercise of options ("Options") under the Accrol Group Management Incentive Plan (the "Accrol MIP"). The Options were granted on 15 May 2018 and vested and became exercisable from 14 July 2021 in accordance with the rules of the Accrol MIP.

The Options were exercised by Dan Wright (Executive Chairman), Gareth Jenkins (Chief Executive Officer), two other PDMRs and one other employee (the "Share Option Participants").  Details in relation to the Option Shares issued to the two directors and the two other PDMRs are contained in the table below.

Some of the Share Option Participants have today sold, in aggregate, 2,962,566 Option Shares at a price of £0.43 per Option Share only in order to finance the cost of exercising the options, the resulting income tax and National Insurance liabilities. Dan Wright sold no shares to fund the liabilities arising from the exercise of his options.

Following the exercise of Options and the sale of Option Shares, a total of 6,193,773 Ordinary Shares, which are still held by Share Option Participants, are subject to lock in arrangements whereby 4,957,404 Ordinary Shares cannot be sold until 1 August 2021 and 1,236,369 Ordinary Shares cannot be sold until 23 July 2022.

Following the exercise and sale of Option Shares by the Share Option Participants, the below directors and PDMRs have increased their aggregate holdings from 5.02% to 6.31% of the issued share capital of the Company.  The table below details their interests in the share capital of the Company:

Director
Position
Ordinary Shares held previously
% of total issued share capital
Number of Ordinary Shares over which Options exercised
Number of Ordinary Shares sold
Resulting total number of Ordinary Shares held
% of enlarged issued share capital
Dan Wright
Executive Chairman
9,972,726
3.20%
1,310,259
Nil
11,282,9852
3.54%
Gareth Jenkins
Chief Executive Officer
4,265,632
1.37%
2,198,466
1,041,169
5,422,9293
1.70%
Mark Dewhurst
PDMR
1,045,975
0.34%
2,000,690
967.565
2,079,100
0.65%
Graham Cox
PDMR
350,970
0.11%
1,856,0931
879,025
1,328,038
0.42%
TOTAL
15,635,303
5.02%
7,365,508
2,887,759
20,113,052
6.31%

 

1
This number includes a discretionary award that was made to Graham Cox by Accrol's Remuneration Committee under the Accrol MIP of options over 1,060,638 Option Shares
2
8,244,155 of these shares are registered in the name of Gomrath Limited, a family investment company controlled by Dan Wright
3
3,741,346 of these shares are registered in the name of Gareth's wife Susan Jenkins

               

Following the above exercise of Options, there are no longer any unexercised options over Ordinary Shares under the Accrol MIP.

Admission and Total Voting Rights 

Application has been made for the 7,523,465 new Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission and dealings in those shares will commence at 8.00 a.m. on 28 July 2021.

The Company advises that, immediately following Admission, there will be 318,878,097 Ordinary Shares in issue, with one voting right each. The Company does not hold any shares in treasury. The number of Ordinary Shares with voting rights will therefore be 318,878,097. Accordingly, this number should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 


 1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Dan Wright
2
Reason for the notification
a)
Position/status
Executive Chairman
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Accrol Group Holdings plc
b)
LEI
213800MC56M5G69RJ226
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of £0.001 each
ISIN: GB00BZ6VT592
b)
Nature of the transaction
Exercise of options
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£0.001
1,310,259
d)
Aggregated information
- Aggregated volume
- Price
N/A - Single transaction
e)
Date of the transaction
23 July 2021
f)
Place of the transaction
London Stock Exchange, AIM

 

 


 1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Gareth Jenkins
2
Reason for the notification
a)
Position/status
CEO
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Accrol Group Holdings plc
b)
LEI
213800MC56M5G69RJ226
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of £0.001 each
ISIN: GB00BZ6VT592
b)
Nature of the transaction
(i) Exercise of options
(ii) Sale of Ordinary shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
(i) £0.001
(ii) £0.43
2,198,466
1,041,169
d)
Aggregated information
- Aggregated volume
- Price
(i) Price - £0.001
Volume - 2,198,466
(ii) Price - £0.43
Volume - 1,041,169
e)
Date of the transaction
23 July 2021
f)
Place of the transaction
London Stock Exchange, AIM

 

 


 1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Mark Dewhurst
2
Reason for the notification
a)
Position/status
PDMR
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Accrol Group Holdings plc
b)
LEI
213800MC56M5G69RJ226
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of £0.001 each
ISIN: GB00BZ6VT592
b)
Nature of the transaction
(i) Exercise of options
(ii) Sale of Ordinary shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
(iii) £0.001
(iv) £0.43
2,000,690
967,565
d)
Aggregated information
- Aggregated volume
- Price
(i) Price - £0.001
Volume - 2,000,690
(ii) Price - £0.43
Volume - 967,565
e)
Date of the transaction
23 July 2021
f)
Place of the transaction
London Stock Exchange, AIM

 


 1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Graham Cox
2
Reason for the notification
a)
Position/status
PDMR
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Accrol Group Holdings plc
b)
LEI
213800MC56M5G69RJ226
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of £0.001 each
ISIN: GB00BZ6VT592
b)
Nature of the transaction
(i) Exercise of options
(ii) Sale of Ordinary shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
(iii) £0.001
(iv) £0.43
1,856,093
879,025
d)
Aggregated information
- Aggregated volume
- Price
(i) Price - £0.001
Volume - 1,856,093
(ii) Price - £0.43
Volume - 879,025
e)
Date of the transaction
23 July 2021
f)
Place of the transaction
London Stock Exchange, AIM

 

 

For further information, please contact:
Accrol Group Holdings plc
Dan Wright, Executive Chairman
Via Belvedere Communications
Gareth Jenkins, Chief Executive Officer
Richard Newman, Chief Financial Officer
Zeus Capital Limited(Nominated Adviser & Broker)
Dan Bate / Jordan Warburton
Tel: +44 (0) 161 831 1512
Dominic King / John Goold
Tel: +44 (0) 203 829 5000
Liberum Capital Limited (Joint Broker)
Tel: +44 (0) 20 3100 2222
Clayton Bush / Edward Thomas
Belvedere Communications Limited
Cat Valentine
Tel: +44 (0) 7715 769 078
Keeley Clarke
Tel: +44 (0) 7967 816 525
Llew Angus
Tel: +44 (0) 7407 023 147
accrolpr@belvederepr.com

 

Overview of Accrol

 

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisitions of LTC in Leicester and JD in Flint, North Wales, the Group now operates from six manufacturing sites, including four in Lancashire, which generate revenues totalling c.16% of the £2.1bn UK retail tissue market.

 

For more information, please visit www.accrol.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHFLFFVDDIVFIL